# Do drug claims need an 11-digit or 12-digit NDC?

Canonical: https://prospyrmed.com/resources/practice-answers/ndc-format-drug-billing
Sources reviewed: 2026-09-16 · Prepared by Prospyr

Follow the payer’s required transaction format, not a guessed conversion. FDA’s 12-digit NDC transition takes effect March 7, 2033 and does not change the separate HIPAA 11-digit reimbursement format. Preserve the package identifier and verify how the billing system represents it.

## Separate the label from the claim format

FDA explains that the new uniform label format is distinct from reimbursement formats used for other purposes. An NDC identifies a listed drug product and package; it is not a HCPCS code, billing increment or guarantee of FDA approval or coverage.

Source: [FDA: National Drug Code format](https://www.fda.gov/drugs/electronic-drug-registration-and-listing-system-edrls/national-drug-code-format) — FDA format transition; separate reimbursement formats

## Maintain a traceable crosswalk

Your operating reference should connect the actual package, manufacturer, product strength, package size, inventory item and payer-specific claim format. This is an internal reconciliation recommendation. Have a qualified billing reviewer validate formatting rules rather than letting staff pad zeros by memory.

Source: [FDA: National Drug Code format](https://www.fda.gov/drugs/electronic-drug-registration-and-listing-system-edrls/national-drug-code-format) — FDA format transition; separate reimbursement formats

## Practical checklist

1. Capture the identifier exactly as printed on the package.
2. Confirm the payer’s current NDC format and unit-of-measure requirements.
3. Keep the original package identifier alongside the transmitted value.
4. Revalidate mappings when suppliers or package sizes change.

## Worked example

A new package arrives with a different identifier. The team should update and review the package crosswalk instead of reusing the old NDC because the brand name is unchanged. Track the source label and reviewer so the next discrepancy is resolvable.

## Mistakes to avoid

- Replacing an NDC with a J-code.
- Treating an FDA format announcement as an immediate payer-format change.
- Assuming an identifier alone proves approval or insurance coverage.

## Related questions

- [Do Botox, Dysport, Xeomin and Myobloc use the same billing units?](https://prospyrmed.com/resources/practice-answers/botulinum-toxin-j-codes)
- [What should an injectable lot and recall log track?](https://prospyrmed.com/resources/practice-answers/drug-lot-recall-tracking)
- [How do you calculate J0585 billing units for Botox?](https://prospyrmed.com/resources/practice-answers/j0585-botox-billing-units)

Prepared by Prospyr from the cited primary sources. These are educational workflow resources, not individualized clinical, coding, legal or tax advice. No clinician, certified-coder or attorney review is claimed. Confirm current code instructions, payer terms and applicable law for the actual service and date. CPT is a registered trademark of the American Medical Association; this is not a substitute for a licensed current code set.